Thirty Holstein bull calves were used to investigate the use of an injectable solution of purified Ig to increase Ig in serum of neonatal calves. The Ig were from abbatoir blood purified by column chromatography. Calves were blocked by date of birth and assigned randomly to treatment within block. Treatments were 
INTRODUCTION
Morbidity and mortality of the neonatal calf are of significant economic concern to beef and dairy producers. A recent national dairy heifer survey (5) reported that preweaning mortality of heifer calves born alive or moved onto an operation was 8.4% (SE = .4). Economic losses to producers include the cost of the calf and investments in feed, housing, health care, and labor.
Calves are born hypogammaglobulinemic; therefore, consumption of colostrum is required to provide passive immunity until calf immunity is established (4) . For approximately 24 h after parturition, intestinal epithelial cells absorb macromolecules, such as Ig (9, 16, 17) , which are transported through the cell to the lymphatic system and then to the general circulation (4, 16) . Thereafter, absorption of macromolecules ceases, and chances of acquiring passive immunity are terminated. If calves do not ingest a sufficient mass of Ig prior to cessation of macromolecular transport, increased morbidity and mortality may occur (7, 13) . Klaus et al. (10) reported that 30% of calves consuming colostrum may remain hypogammaglobulinemic. More recently, a USDA survey (5) reported that 41% of 2177 calves sampled between 24 and 48 h of age failed to attain serum IgG concentration of 10 g/L. Furthermore, 53.6% of mortality risk among calves with IgG concentration in serum <IO g/L was associated with inadequate Ig transfer and colostral intake. The degree of acquisition of passive immunity is dependent on several factors, including age at first colostral feeding and mass of Ig consumed (11, 17). Therefore, techniques are needed to provide Ig to hypogammaglobulinemic calves after cessation of macromolecular transport by intestinal epithelium. Techniques such as serum transfusions are possible but difficult, time-consuming, and costly. Purified Ig preparations (3, 1568 CRAWFOR 6) have the potential to provide Ig via injection with lower cost. Our objectives were to evaluate the effect of an injectable solution of purified Ig on serum Ig concentrations, growth, and intake in hypogammaglobulinemic calves.
MATERIALS AND METHODS

Experimental Design
Holstein bull calves (n = 30) were blocked by date of birth and assigned randomly within block to one of five treatments. Treatments were S.C. injection of .9% NaCl with (+) or without (-) colostrum feeding (CF), 30 mg of Ig/ml in lactated Ringer's injection @,30), 30 mg of Ig/ml in .9% NaCl 630), or 60 mg of Ig/ml in .9% NaCl (S60). Calves on CF-, L30, S30, and S60 treatments were fed 4 L of milk replacer by 24 h of age, and calves on CF+ treatment were fed 4 L of pooled colostrum by 24 h of age. Calves were injected by 24 h of age. The volume of solution administered was calculated to provide serum Ig concentration of 7.5 g/L. Serum volume was assumed to be 7% of BW (14). The volume of solution administered was calculated as the mass of Ig to inject divided by Ig concentration in the solution.
The Ig solution (American Protein Corp., funes, IA) was from bovine abattoir blood, separated and purified by ion-exchange chromatography (6) and suspended in .9% NaCl. The solution was obtained in three lots and averaged 6.2% total protein (SE = .05) and 6.1% IgG (SE = .04). The Ig solution was diluted in .9% NaCl or lactated Ringer's injection and delivered by S.C. injection. Large amounts of solution (>.5 L) were delivered by multiple injections. Calves on CF+ and CFtreatments were injected with .9% NaCl using volumes for treatments of 30 mg/ml. The S.C. route of administration was chosen because it would be more readily incorporated into the management of calf growers. Many calf raisers routinely provide electrolytes S.C. to neonatal calves purchased from sale barns and transported long distances. The NaCl and lactated Ringer's injection were used to compare the effect of diluent on absorption of fluid and Ig by the calf.
As soon as possible after birth and prior to nursing the dam, calves were moved to the experimental facility and placed in an individual pen (2 m ) bedded with shavings. Calves on L30, CF-, S30, and S60 treatments were fed 2 L of milk replacer (Maxi-Lac@; Tennessee Farmers Cooperative, LaVergne, TN) upon arrival and at 12-h intervals until 48 h of age. Calves on CF+ treatment were fed 2 L of pooled colostrum (mean IgG = 41.1 g/L; SE = 8.2) upon arrival and at 12-h intervals until 48 h of age. Mean age at first feeding was 1.5 h (SE = .2). Thereafter, all calves received milk replacer reconstituted to 14% DM at 10% of BW in two equal feedings at approximately 0800 and 1600 h. Amount of milk replacer offered was adjusted weekly. Commercial calf starter (Co-op Starter/Grower Course-Dec; Tennessee Farmers Cooperative) was offered for ad libitum consumption once daily from 4 d of age. Amounts of milk replacer and starter consumed were measured at each feeding. Water was available at all times.
Sampling and Analysis
Calves were weighed upon arrival at the experimental facility and every 7 d until 28 d. Samples of milk replacer and calf starter were collected weekly, composited by month, and analyzed for DM, CP, ash, ether extract (I), NDF (8), Ca, P, Mg, and K by atomic absorption spectrophotometry ( Table 1) . Fecal consistency was scored at the a.m. feeding by the 
Statistical Analysis
The Ig concentrations in serum at 48 h postinjection and at 28 d were analyzed as a randomized complete block experimental design by analysis of covariance, IgG, and IgM at 0 h as covariables. Weekly intake of starter and milk replacer, BW, feed efficiency, mean rectal temperatures, fecal scores, and respiration rates were analyzed by repeated measures ANOVA (15) using a randomized complete block design. Significance was P < .05 unless otherwise indicated.
RESULTS AND DISCUSSION
Morbidity and Mortality
Two calves died during the study. In both incidences, death occurred <1 wk of age. Necropsy determined that death was caused by septicemia. Calves were from treatments L30 and CF-and were not replaced. Therefore, least squares means are presented.
Respiration rates tended to be affected by an interaction of age by block (P < .IO), which may have been due to changes in ambient temperature during the study. Mean respiration rate was 31 (SE = 1). Rectal temperatures tended to be affected by age of calf (P c .lo) but were unaffected by treatment. Mean rectal temperature was 38.6"C.
Calves injected with Ig tended to experience less severe scouring than calves on CF-treat- Absorption of fluid and Ig from the injection site normally required approximately 10 h from the beginning of the first injection until all solution was absorbed (no visible swelling in the injection area). No obvious difference existed between diluents or concentration of Ig solution on rate of absorption. Occasionally, the injected solution appeared to migrate ventrally along the side of the calf, possibly as a result of the density of the solution. Injections made near the shoulder tended to allow accumulation of material near the joint, producing mild discomfort to the calf when walking. This effect was transient and usually lasted c2 d.
BW, Intake, and Feed Efficiency
No effects of treatment were observed on BW at 28 d, average daily BW gain, intake of calf starter, DM, CP, or feed efficiency (Table  2) . However, calves on CF+ treatment tended to have lower initial BW (P c .lo) than other calves, which reduced consumption of DM and CP from milk replacer. Changes in intake and BW with increasing age were unaffected by treatment and were indicative of normal intake and growth for calves during mo 1 of life. Calves deprived of colostrum during the first 24 h postpartum often experience increased morbidity and mortality (5, 7, 14, 17) and reduced BW gain and intake (13) . These data suggest that depressions in BW gain and intake in calves deprived of colostrum may be a function of disease exposure rather than a function of one or more components of colostrum. Our calves were isolated from other calves, and strict hygiene practices were followed. Intake of feed and BW gain were similar among calves fed colostrum, calves injected with Ig solution, and those remaining hypogammaglobulinemic.
Serum Ig
Serum IgG and IgM concentrations at 0 h were consistently below the minimum limits of the radial immunodiffusion assay and indicated that calves had not suckled the dam prior to being transported to the experimental facility. Concentrations of IgG in serum of calves injected with Ig did not reach 10 g/L, which is considered successful transfer of passive immunity (7). It is probable that the target concentration of 7.5 g of IgGL of serum was not achieved because insufficient Ig was administered. Differences in expected and actual concentration of Ig solution accounted for differences in expected and actual Ig administered.
The Ig in maternal colostrum reflect the disease exposure of the cow and is an excellent source of Ig for the calf, which may be exposed to similar antigens. The Ig provided by s.c injection do not necessarily reflect the "disease history" of the farm and should not be considered a replacement for maternal colostrum. Instead, sources of Ig other than maternal colostrum should be utilized only when maternal colostrum is unavailable or is of poor Ig composition.
CONCLUSIONS
Subcutaneous injection of bovine Ig provided moderate circulating concentrations of Ig and appears to be a viable option for hypogammaglobulinemic calves that are older than 24 h. Concentrations to 60 g of Ig/L of injectable solution in .9% NaCl or lactated Ringer's injection were satisfactory. Increasing the amount of Ig injected may increase circulating concentrations to provide greater protection for hypogammaglobulinemic calves. Further study is required to determine the optimal route and amount of administration and efficacy in maintaining calf health.
